Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology. Velocity Partners VC led the round with co-leaders Evercurious VC, alongside major participation from Relativity Healthcare Partners. Boston-based Anodyne plans to use proceeds to support the advancement of ANN-101, its once-weekly GLP-1 patch for obesity. […]
